Autres langues Ashland Inc.

Actions

ASH

US0441861046

Chimie diversifiée

Marché Fermé - NYSE 22:00:03 01/09/2026			Varia. 5j.	Varia. 1 janv.
75,64 ^USD	+3,74%		+2,62%	+28,92%

24/08	Ashland Inc. lance Permexa Sodium Caprate pour soutenir le développement à grande échelle et la commercialisation de peptides oraux, de produits biologiques et de médicaments à faible perméabilité	CI
12/08	Ancora offre jusqu'à 1,2 milliard de dollars pour une activité de H.B. Fuller

Autres langues

01/09	Ashland to host Innovation Day for analysts and investors
24/08	Ashland Inc. Launches Permexa Sodium Caprate to Support Scalable Development and Commercialization of Oral Peptide, Biologic and Low-Permeability Drug Products
24/08	Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
24/08	Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
13/08	Ancora offers up to $1.2bn for an H.B. Fuller business
12/08	Ancora offers to buy H.B. Fuller's adhesive unit for up to $1.2 billion in cash
11/08	Ashland Reportedly Considers Sale Following Ancora Settlement
10/08	Ashland Inc. Announces Board and Committee Appointments, Effective August 7, 2026
07/08	Specialty chemicals firm Ashland weighs sale amid activist push, sources say
07/08	Specialty chemicals firm Ashland weighs sale amid activist push, Bloomberg News reports
07/08	Ashland board authorizes quarterly dividend
07/08	Ashland Inc. Declares Quarterly Dividend, Payable on September 15, 2026
07/08	Ashland Explores Potential Sale Following Takeover Interest
06/08	Ashland's Fundamentals Appear to Improve With a Fiscal Q3 Beat, Morgan Stanley Says
28/07	Ashland Fiscal Q3 Adjusted Earnings Fall, Revenue Rises
28/07	(ASH) Ashland Reaffirms 2026 Revenue Outlook Range $1.84 Billion-$1.87 Billion, vs. FactSet Est of $1.85 Billion
28/07	Ashland: Fiscal Q3 Earnings Snapshot
28/07	Ashland Enters into Cooperation Agreement with Ancora
28/07	Ashland Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026
28/07	Earnings Flash (ASH) Ashland Inc. Reports Q3 Revenue $497.0M, vs. FactSet Est of $486.0M
28/07	Earnings Flash (ASH) Ashland Inc. Posts Q3 Adjusted EPS $1.02 per Share, vs. FactSet Est of $0.98
28/07	Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook
28/07	Ashland Inc. Reaffirms Earnings Guidance for the Full Year Fiscal 2026
28/07	Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora
28/07	Ashland Inc. Announces Board and Committee Changes